Figure 1. Establishment and performance evaluation of the nine-lncRNA signature for MFS of breast cancer patients in the training dataset.
(A) The ROC curves for MFS prediction by the nine-lncRNA signature in the training dataset. (B) Kaplan-Meier analysis for MFS of breast cancer patients using the nine-lncRNA signature in the training dataset. (C) The distribution of the metastasis risk score, patients’ metastasis status and lncRNA expression in the training dataset.